View our virtual symposium presented at CNS 2020, which summarizes the characteristic clinical features of AADC deficiency
Review pediatric disorders that may clinically resemble AADC deficiency, including cerebral palsy, epilepsy, and certain neurotransmitter disorders
Clinical experience with differential diagnosis of AADC deficiency is discussed
Current management options and treatments in development for AADC deficiency are discussed. This includes an investigational gene therapy currently in development for AADC deficiency
This virtual symposium was hosted by PTC Therapeutics at the 2020 CNS Annual Meeting in Charlottesville, NC, USA; it was developed and funded by PTC Therapeutics; this meeting was not an official program of CNS 2020.
This virtual symposium recording has been chapterized to enable ease of viewing.
Register now to unlock the content
Register now to access the content on this page
If not, register below
GL-AADC-0702 | June 2021
Sign in or register to access exclusive content on this site
Some cookies are essential, others help us improve your experience by providing insights into how the website is used. Select one or more of the cookie types listed below, and then save your preferences. Refer to our Cookies Statement for more information.
Performance cookies, which help us measure the website’s performance and improve your experience. In using performance cookies we do not store any personal data, and only use the information collected through these cookies in aggregated and anonymised form.